Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zeigler

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Neurocritical Care|September 15, 2005
Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantationWalter S Bartynski, Zella R Zeigler, Richard K Shadduck, et al.
American Journal of Hematology|October 1, 1989
Leukostasis: a phenomenon of prolymphocytic leukemiaA M Megaludis, A Winkelstein, Z R Zeigler, et al.
British Journal of Haematology|March 1, 1992
Unmaintained trilineage response to recombinant human erythropoietin in a patient with myelodysplasiaD Jones, Z R Zeigler, C S Rosenfeld, et al.
Bone Marrow Transplantation|January 1, 1996
Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathyZ R Zeigler, R K Shadduck, R Nath, et al.
American Journal of Clinical Oncology|April 1, 1997
Phase II study of roquinimex in myelodysplastic syndromeC S Rosenfeld, Z R Zeigler, R K Shadduck, et al.
Psychosomatic Medicine|November 1, 1993
Blood platelet responsivity to acute mental stressS B Malkoff, M F Muldoon, Z R Zeigler, et al.
Arthritis and Rheumatism|January 1, 1988
Interleukin-1 activates phospholipase A2 in human synovial cellsS C Gilman, J Chang, P R Zeigler, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300iJeffrey Gryn, Richard K Shadduck, John Lister, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|May 1, 1996
Two phase treatment of a severe Class II, division I malocclusionR G Keim, B Collins, C Morgando, et al.
Leukemia & Lymphoma|July 1, 1993
Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cellsJ Nemunaitis, V Albo, Z R Zeigler, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Neurocritical Care|September 15, 2005
Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantationWalter S Bartynski, Zella R Zeigler, Richard K Shadduck, et al.
American Journal of Hematology|October 1, 1989
Leukostasis: a phenomenon of prolymphocytic leukemiaA M Megaludis, A Winkelstein, Z R Zeigler, et al.
British Journal of Haematology|March 1, 1992
Unmaintained trilineage response to recombinant human erythropoietin in a patient with myelodysplasiaD Jones, Z R Zeigler, C S Rosenfeld, et al.
Bone Marrow Transplantation|January 1, 1996
Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathyZ R Zeigler, R K Shadduck, R Nath, et al.
American Journal of Clinical Oncology|April 1, 1997
Phase II study of roquinimex in myelodysplastic syndromeC S Rosenfeld, Z R Zeigler, R K Shadduck, et al.
Psychosomatic Medicine|November 1, 1993
Blood platelet responsivity to acute mental stressS B Malkoff, M F Muldoon, Z R Zeigler, et al.
Arthritis and Rheumatism|January 1, 1988
Interleukin-1 activates phospholipase A2 in human synovial cellsS C Gilman, J Chang, P R Zeigler, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300iJeffrey Gryn, Richard K Shadduck, John Lister, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|May 1, 1996
Two phase treatment of a severe Class II, division I malocclusionR G Keim, B Collins, C Morgando, et al.
Leukemia & Lymphoma|July 1, 1993
Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cellsJ Nemunaitis, V Albo, Z R Zeigler, et al.
Pageof 8